SCHEMBL23965749

SCHEMBL23965749

CCN(CCOC)c1nc2ccccc2s1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 3/20 0.53
▸ MEN1 O00255 3/20 0.51
▸ KMT2A Q03164 3/20 0.51
▸ ALOX15 P16050 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ PPARD Q03181 6/20 0.44
▸ NPC1 O15118 3/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ RAB9A P51151 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ CASP3 P42574 1/20 0.42
▸ SENP8 Q96LD8 1/20 0.42
▸ SENP7 Q9BQF6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23965742 0.93 MEN1 (0.54) PPARGMEN1KMT2AALOX15TSHR
SCHEMBL10387972 0.85 CYP3A4 (0.52) PPARGMEN1KMT2AALOX15TSHR
SCHEMBL23965747 0.82 PPARD (0.47) MEN1KMT2APPARDNPC1SMN1; SMN2
SCHEMBL21638287 0.81 SMN1; SMN2 (0.46) PPARGMEN1KMT2ANPC1SMN1; SMN2
SCHEMBL21664333 0.80 NPC1 (0.50) PPARGMEN1KMT2AALOX15TSHR
SCHEMBL28656001 0.77 PPARG (0.45) PPARGMEN1KMT2AALOX15TSHR
SCHEMBL21511146 0.75 MEN1 (0.47) MEN1KMT2AALOX15TSHRNPC1
SCHEMBL21675474 0.74 MEN1 (0.46) MEN1KMT2AALOX15TSHRNPC1
SCHEMBL18873116 0.74 MEN1 (0.46) PPARGMEN1KMT2AALOX15TSHR
SCHEMBL18997843 0.74 NR1I2 (0.51) MEN1KMT2AALOX15TSHRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161830-B2 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same FUJIFILM CORPORATION (JP) 2021-11-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11161830-B2 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same HAVCR2, HBS1L, PHKB PPARG 3193/4885MEN1 2649/4885KMT2A 2334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback